Related Experiment Video
Updated: Aug 11, 2026

Assessment of Intestinal Transcytosis of Neonatal Escherichia coli Bacteremia Isolates
Published on: February 17, 2023
Therapy for acute infectious diarrhea in children
1Department of Pediatrics, University of Texas Medical School, Houston 77030.
Antidiarrheal compounds are generally not recommended for children with acute infectious diarrhea. Antimicrobial therapy is beneficial for specific infections, but pathogen identification is crucial for effective treatment.
Area of Science:
- Pediatric infectious diseases
- Gastroenterology
- Pharmacology
Background:
- Acute infectious diarrhea is a common pediatric illness.
- Treatment strategies involve antidiarrheal compounds and antimicrobial agents.
- Current recommendations guide therapeutic approaches.
Purpose of the Study:
- To review current therapeutic recommendations for acute infectious diarrhea in children.
- To evaluate the role of antidiarrheal compounds and antimicrobial agents.
- To highlight the importance of pathogen identification.
Main Methods:
- Literature review of current guidelines and studies.
- Analysis of therapeutic indications and contraindications.
- Discussion of antimicrobial efficacy and safety in pediatric populations.
Main Results:
- Antidiarrheal compounds are generally not indicated and can interfere with diagnosis.
- Antimicrobial therapy is effective for specific bacterial and parasitic infections but not viral ones.
- Fluoroquinolones are not approved for children due to potential side effects.
- Accurate pathogen identification is essential for appropriate antimicrobial use.
Conclusions:
- Antidiarrheal agents should be used cautiously in children.
- Antimicrobial therapy is valuable for specific enteropathogens, requiring precise diagnosis.
- Management of diarrhea in immunocompromised children may be complex and prolonged.
Related Concept Videos
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Acute Pyelonephritis II: Diagnostic Studies and Management
Acute Kidney Injury V: Interprofessional Care
Bacterial Gastroenteritis
Cholera

